SINOMED acquires 72.73% stake in eLum Technologies for $20.73M

SINOMED announced the acquisition of a 72.73% equity interest in U.S.-based eLum Technologies, Inc. for USD 20.73 million, marking its entry into the neurointerventional device market. The transaction gives SINOMED control of approximately 90.91% of eLum.

“SINOMED today announced the acquisition of 72.73% equity interest in U.S.-based eLum Technologies, Inc. for USD 20.73 million (approximately RMB 152 million) in self-raised funds.”sinomed.com

• 1 source
• sinomed.comSINOMED Strengthens Neurointerventional Platform with Strategic Acquisition of 72.73% Stake in U.S. eLum Technologies - SINOMEDSinoMed_adminSep 7, 2023

Summarized from public sources; check the original articles before acting on it.